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INTRODUCTION
Polyeythemie is a term that means an increase in
the number of circulating red blood cells above nor
mAl; polycythemia is of two types, primary and secon
dary, or erythrocytosis.

Erythrocytosis is an in

crease in the red blood cells due to some known stim
ulus or simply due to dehydration.

It is character

ized by a moderate increase in hematocrit value and
total red blood cell mass.

It can be caused by iow

oxygen tension of the inspired air and by impaired
oxyp:enetion of the bl.cod in the lungs due either to
congenital heart.disease or any lunp disease which
decreAses the aerating surface of the lungs.

Ery

throcytosis is always benign and is a physiological
response to some known stimulus.
Primary polycythemia, polycythemie vera, or ery
thremia, on the other hand, is a disease of unknown
etio1 ogy, and is a slowly and intermittently pro-.
gressive, ultjmately fatal disease.

It is character

ized by a str5kinR increase in the number of circu
lating red blood cells and in the total blood volume,
as well es by evidence of increased bone marrow ac
tivity.

The disease has an insidious onset, is
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usup,lJy chronic in nature, and is without pathogno
monic symptoms and physical signs early.

This paper

will deal almost entirely with the primary polycythe
mia or polycythemia vera, and no attempt will be m�de
to include the second�ry polycyt�emias, although occa
sionally they may be referred to.

The terms polycy

themia vera and erythremia apply to the same disease
entity and will be used indiscriminantly in this pa
per.
'!he disease was first recognized by Vaquez in
1892 es a definite clinical entity, and he sugpested
overactivity of the hemopoietic tissue as a possible
cause.

It was not until 1903, however, that the

clinicAl signs and symptoms of the disease were enu
merated by Osler.

He observed the marked cyanosis,

polyglobulism, and splenomegaly; he considered anox
emis as e possible cause and su��ested X-Ray therapy.
Since this time interest in this disease has increas
ed �reatly and much experimental work has been done
to try to clarify it.

Several different types of

treatment have proven ouite effective in �ivin� symp
t omatic relief end many theories have been advanced
as to the possible cause of this disease.
The disease is more common in males then in
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fe1Il81es; it is most common in the dewish race and is
.extremely rare in Negroes.
case of polycythemie in

A

Lowe(27) re�orted one
negro woman, aRe 45.

She

was the only case found in 35,000 admissions at the
Charity Hospital in New Orleans.

This makes an in

cidence of .003% in that group; the only other case
in the literature was observed �ohn Futcher at
�ohn's Hopkins.
male.

The patient was a 21 year old negro
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I!.'TI OLOGY
The etiology of erythremia has been discussed at
length by many authors; such a condition might arise
as the result of (1) prolongation of the life of the
red blood cells, (2) diminished destruction of the
red blood cells, or (3) increased formation of the
red blood cells.

All workers ere now in aP-reement

that it is not due to increased longevity or to de
creased destruction, but is the result of increased
red b 1 ood cell formation by the hemopoietic tissue.
This seems most loFical because of' the presence of'
increased number of leucoeytes and platelets .As well
as the persistent increased·uric acid excretion.

Not infrequently polychromatophilia And normoblasts
are found which further substantiates this view.
Vaquez, who first recognized the disease, thought
it ��s due to hyperactivity of the hemopoietic tissue.
Whether he referred to a neoplastic origin or not ii
n ot known, but he probably did; et least he was on
the right tract.

The neoplastic theory still is up

held by many authors, but the frequent absence of ab
norme l red blood cells end the absence of invesive
ness does not seem to support this.

Since the
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diseAse concerns pri1l18rily the erythrocyte which is
an inert cell; it is not surprizin� that it does not
show the invasive features of leukemia which is e dis
ease of the rather active leucocytes.

Nevertheless

erythremia usually does show evidence of .associated
1eucob1astic activity: practically always there is an
associated leucocytosis and not infrequently the dis
ease term.inAtes as e myeloblastic leukemia.
The bone marrow contains three different types
of tissue, erythroblastic, leucoblastic, and thromeo
blastic tissue which give rise to the red ce11s,
�ranuler white cells, end the platelets respectively.
Any of these tissues mey be involved singly or in any
combination, and the stimulus which affects the ery
throblastic tissue may be the same one which Affects
the leucoblastic tissue; thus it becomes apparent that
erythremia and leukemia may have a common etiological
factor.

The leucoblastic tissue, however, is peculiar

in that sooner or later it manifests malignant end in
vasive features once it is stimulated to overactivity.
Parkes-Weber, Minot, end Buchman consider erythremia
to be primarily a disease of the red bone marrow sim11iar to leukemia end suggest that the disease is a
types of malignant tumor which is slowly progressive
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and non-invasive. This view is further substantiated
by th e fact that some cases of mye1ogenous

1 eukemia

change into erythremia. · �ome cases start as an unex
plained leucoeytosis Bnd s e v eral years later develop
into a tru e erythremia.

The majority of authors are

in a�reement that polymorphonue1ear 1eucocytosis is
extremely common in polycythemia vera, · and this is
easily understood when it is r ealized that both types
..
o f cells originete 1.n the bone marrow, that is, the
erythrocytes end granular 1. e ucoeytes.

The same stim

ulus· could act on both types of cells and since the
stimulus of both polyeythemia vera ""nd leukemia is
unknown, it could be the same.

Rarely a case of ery

thremia i � reported with a normal white count; even

more inf_reouent is the association of erythremia with
lymphatic leukemia.

This is rar e indeed and so fer

no satisfactory explaination hes been offered; it
pro.bably is merely co.incidental.
Klumpp pnd lierti�(24) reported five cases with
symptoms of both. erythremie and myelogenous leukemia;
they noticed that cases which terminated es myelogen
ous leukemia started with a phase suggestive of ery
thremie. ·Naegli beli e ves that there is an initial
·polyeythemia in the early cases of myelo�enous
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leukemia.

Klumpp and Hertig considered leucocytosis

with immature myeloid cells in true cases of ery
thremie e late mAnisfestation of the disease.

Gheron

and Winter, as quoted by these authors, have reported
cases which started out as myelogenous leukemia and
finally ended up es a true erythremia.

If cases show

signs end symptoms of both diseases, it is more like
ly to terminate as a myelop:enous leukemia than as ery
thremia.

Of the 33 cases found in the literature by

these authors, 12 turned out to be leukemia and 3
were erythremia.

The two diseases certainly appear

to have something in common about their etiology, the
n8ture of which stiJ.1 remains a mystery, as is the
case with other neoplastic diseases.
Israe1(23) reports one case of a 42 year old fe
male who came to the hospital complaining of exhaust
i on end dyspnea on exertion for a period of 9 months
w hich became progressively worse.

Laboratory studies

showed the hemoglobin to be 45�, the red cells 3,030,
000, nucleated red cells 79,000, and white cells 34,
000.

The differential was very interestinp;.se@:IU.ented

neutrophils 43.5%, lymphocytes 12.5%, monocytes 4�,
eosinophils 1%, metarnyelocytes 9%, myelocytes 28%,

rnyeloblasts 2%, reticulocytes 4.8%, primitive norm.o-
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blasts .5%, polychromatic normoblasts 15%, orthochro
matic normoblasts 55%, and mege1ob1asts 25%.

The

petient W8S treated with radiation, arsenic, liver,
iron, and transfusions, but the progression of the
d isease could-not be affected.

The author considers

this to be a nroliferative condition of the immature
red blood cells similiar to that of the white blood

cells in leukemia, tht=it is" a true erythremia which
is ouite malignant.
Osler in 1903 suggested anoxemia as a cause for
this disease; Reznikofr, Foot, and Hethea(38) thought
along the same lines and set out to prove it.

They

made an intensive study of the bone marrow obtained
from biopsy and autopsy materiel from polycythemic
and control patients.

The biopsies on polycythemic

patients were obtained after the red blood cell count

was brought down to normBl by treetment in order to
prevent distention of the vessels.

The results of

this investi�ation showed definitely that the capill
aries of polycythemic patients were distinctly thick
ened.

In most cases the arteries and arterioles of

the bone m�rrow were characterized by subintimal and
edventitial fibrosis; the controls were free from
these 1esions.

In arteriosclerotic individuals the
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f:ibrous tissue was infiltrated in the muscular coat
and the ca-pi lleries were normal or nearly so.

One

case showed infl.aT.etory and necrotic lesions a long
the course of b 1 ood vessels with a cellular exudate
consisting chiefly of lymphocytes end monocytes.

It

is interesting to note here that Anitschkow in his
analysis of 40,000 autopsies reported to the 1934
Congress of InternAtional Association for Ueographie
Pathology at Utrecht that vascu}er sclerosis is much
more prevalent among Jews.

Tb.is could account for

the higher incidence of polycythemia vera among this
race which is an established fact born out by statis
tics.
According to this theory, that is, the enoxemia
theory, erythremia is considered a response of the
bone marrow to a local anoxemia; it must be admitted
that this certainly is a plausible exp1aination.
However, if the oxygen content of the inspired air
is increased the red blood cells should decrease;
this does not occur.

Harrop su�gests that the oxygen

diffusion thru the capillary wall is at fault and
that although the blood is fully oxygenated, the oxy
gen still can not get to the bone marrow thru these
thickened capillaries.

It is evident that the
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pathology lies in the bone marrow and not in the pul

monery system or in the vascular system outside the

bone marrow; this pathology, however, ma_y be the re
sult of the disease rather than the cause of it.

Also in this corµiection it is interesting to

note that Reznikoff reports the frequent association

of erythremia with thrombo-angitis obliteraris; he

does not, however, support his statement by clinical
cases • . Silbert(40) reports three cases of polycy

themia vera associated with thrombo-angitis oblit
erans. In all three cases the diagnosis was made

several years After the patient had been treated for

thrombo-angitis obliterans.

Of the 198 cases of

polyeythe�ia vera observed at the Mayo Clinic be

tween 1912 and 1936, only one was regarded es having

thrombo-angitis obliterans.

The three cases report

ed by Silbert were taken from a series of 100 cases
at the Mount Sinai Hospital in New York during the

last 20 years, and were observed and treated by N.

Rosenthal and F. Bassen.- Silbert has only observed

3 cases in which erythremia developed in 1300 cases
of thrombo-angitis obliterans.

Considering the in

frequency with which both diseases occur in the same
patient, it seems lo�ical to assume that the two
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diseases do not have e com:tnon etiological factor, and
the association of the two diseases should be regard
ed merely as coincidental.
Hollock, as cited by Reznikoff, measured the lac
tic acid content of polycythemic blood end found it
increAsed in the quiesent state; with mild exercise
and hot baths th� blood lactic acid decreased.

The'

lactic acid remained elevated even after the red blood
cell �aunt was reduced by therapy.

Rollock, there�

fore, concluded that some factor such as vasoconstric
tion is responsible and that polycythemia is secon
dary to it.

He suggested anoxemia as an important

factor in the production of this disease •

.Morris advanced another theory on the etiology

of erythremie; he suggested that it is the antithesis
of pernicious anemia and that the disease was due to
the excess production of the erythrogenic factor by
the stomach.

He based his theory on the observation

that frequent lavage of the stomach of patients suf
fering from erythremia reduced the red blood count,
but this was not substantiated by other authors.
Adamson(l) became interested in this theory and
did considerable experimental work with white rats.
He used? rats in each group and he treated 8 groups;
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one group was treated in each of the fo11.owin11- ways.
(1) s.Q. injection of normal gastric juice.

(2) s.Q. injection of ·normal gastric juice taken
30 min. after the injection of .00075 gm. of

histemine.

(3) S.Q. injection of gastric juice from a pernieious anemia p�tient.

(4)

S.Q. injection of gastric juice from a per-

nicious anemia patient taken 30 min. after the
injection of .00075 gm. of histamine.

(5) S.Q. injection of gastric juice from a polycy
themia vera patient.

(6) S.Q. injection of gastric juice from a :polycy

themia ve�a patient taken �O min. after the in
jection of .00075 gm. of histamine.

(7) S.Q. injection of gastric juice from a second
polycythemia vera.patient.

(8) s.Q. injection of gastric juice from a second

polyeythemia ve:ra patient taken 30 min. after
the injection of .00075 gm. of histamine.

Adamson came to the following conclusions on

these experiments. Norm.al gastric juice contains an

intrinsic factor which stimulates red blood cell for

mation and this is increased following histamine
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injection.

This substance is absent in the gastric

juice of pernicious Anemia patients and is not in

c reased by histamine in these patients.

This sub

stance is increased in the gastric juice of patients
suffering from erythremia and it is not further in
creased by histamine injection.

This observation

may indicate that the intrinsic substance, which is

freouently called "Addisin", is present in excessive

amount in the gastric juice of patients suffering

from poJycythemia vera, or that the patient is un

usually sensitive· to this substance so that a maximum

amount of �emopoieti_c substance is constantly produc
ed.

If this is· true additional light is thrown on

the etiology of polycythemia vera.

Morris, as cited by Wilbur, treated one of his

erythremic patients by_lavaging the stomach 3 or 4

times a day in an attempt to diminish the intrinsic

factor, "addisin".

In the course of 6 months the

patient's red cell count fell from 10 to 5.3 million;

a few months after the lavage was discontinued, the

· red cell count rose again to 10.2 million.

This pa

tient also had a duodenal ulcer and it was cured by
this treatment.

Boyd reports one case of pol.ycythe

mie associated with duodenal ulcer end he regarded
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it as coincidental.

Wilbur end Ochsner(45) of the

Meyo Clinic report an incidence of 8% in 143 cases
reviewed.
Kraemer and Asher(25} observed two patients with
polycythemia vera associated with duodenal ulcer, and
both were Russian Jews.

The gastro-intestinal com

plaints predominated in both cases; one patient was
given biweekly lavages with sodium bicarbonate for
three months.

His epigastric distress disappeared

but his red cell count and hemo�lobin remained hi�h.
Oerting and Brig�s(34) lavaged their patients
4 to 6 times weekly and got a reduction in the red
cell count end hemo�lobin.

The difficulty in per

suading a symptomi.ess ·patient to consent to such
treatment is easily realized.

Ulcer patients, how

ever, p:et such marked relief from this procedure that
they would consent to such treatment for lon� periods
of time.

To be effective at least 700 cc must be

removed daily and then if no effect is obtained in
4 to 6 weeks, this method of therapy probably will
not work.

Oerting and Briggs suggest doing a par

tial gastrectomy in the patients relieved by lavage
to accomplish a permaEent cure.

Singer reports such

a case; the patient underwent a partial gastrectomy
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and shortly afterward his red cell count returned to
normal and remained there.

Since this is an isolated

case its significance is hard to evaluate.

The exact

cause of the freauent association of peptic ulcer
with polycythemia vera has not been determined, but
it may be due to several factors.

Increased intrin

sic factor and hydrochloric acid have been sug�ested;
the most logical explaination appears to be throm
bosis of the gastric or duodenal vessels.

Thrombo

sis is so frequent in erythremia that it is consider
ed a pert of the disease.

Although thrombosis is

more prone to occur in the cerebral, coronary, and
mesenteric vessels as well as in the vessels of the
lower extremities, it can occur in any part or organ

of the body.
Middleton, as cited by Oerting, tried stomach
lavage on e patient with a red cell count of 9,000,
000.

Lavape was performed two times daily and after

several weeks the patient's red cell count came down
to 6,500,000; but after six more weeks of constant
treatment, his red count went back up to the original
height of 9,000,000.

'l'arror had the same experience.

In view of the confli9ting evidence on this theory it
appears that the authors might have been dealing with
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two separate disease entities, that is, familial
polycythemia, which is rather benign, end non-famil
ial polycythemia which comes on later in life and is
more progressive, or that the cause of erythremia is
not always the sAme.
Bernstein, as quoted by Nadler, was the first
to report data on the blood of both patient and rel
ative and thus has been given the credit of reporting
the first case of familial polycythemia.
report in 1914 on a father and son.

he made his

In 1920 Engel

king reported the incidence of the disease in three
generations of one family, the grandmother, mother,
and five children. · Four years later Wieland report
ed in one family a mother, three sons, end one daugh
ter with red counts from 8 to 12 million, end he be
lieved that the disease was constitutional and hered
itary.

For a time familie l polycythemia we s consid..

ered to be a senarate disease entity because many
patients suffering from this disease were symptom
free in s�ite of high red cell counts.

However, when

Heden(l9) laid down the criteria that a greatly in
creAsed red blood cell mess is the essential feature
of the disease, and since this was present in almost
all the cases of familial polycythemia, they were
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considered as the same entity.
Whether the cases of heredofamilial erythremia

are the same disease as true erythremia is, however,
still open to question.

In the heredofamilial type

the course is usually much more benign, may produce
no symptoms, and be�ins much earlier in life.

ner(l5), Spodaro, Wieland, And Halbertsma have

Fork

stressed the feet that polymorphonueleer leucocyto
sis, the presence of myeloeytes, and even myelo

blasts in the circulating blood which is so charac

teristic of true erythremia, has invariably been ab

sent in the familial polycythemia and the polyeythe�

mia of childhood.

These ere in fact the chief diff

erences between true erythremia and erythrocytosis.
These authors and several others feel that further

study will permit a differentiation of the two con

ditions into separate disease entities.

A fourth factor has been suspected as causing

erythremia and that is the endocrines.

The suspect

e·d glands include the thyroid, -pituitary, end adre
nals; in pituitary basophilism the red cell count

may be elevated.

Flaks, Himmel, and Zlotnik report

ed that injections of anterior pituitary extract

will increase the red cell count in white rats; this,

however, does not occur in dogs.

In none of these
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conditions was the red count increased enough to be
called an erythremia.
Moehlig and Bates(31) reported two cases of pit
uitary gland disturbance with polycythemia.

In one

case the red count �as 6,640,000, and autopsy report
ed an adenoma of the pituitary g1and which contained
both basophilic and· eosj.nophilic elements.

The sec

ond case was a 63 year old male who had an examina
tion eight months previously and nothing abnormal

was found.

When the patient entered the hospital he

was complaining of vomiting and loss of weight and
this.time his red cell count was 8,194,000.

The pa

tient died in several weeks and autopsy reported a
larp:e invasive tumor of the left kidney with meta stasis to the lungs.

Grossly the pituitary we s

normal but microscopic examination showed hyper
trophy and_hyperplasia of the basophilic elements.
They a1so did some experimental work on dogs;
they did a bilateral adrenalectomy on 11 do�s and ob�
served the blood picture.

Only 4 dogs lived more

than 4 days and in a11 cases an increase in the total
number of circulAting red cells was noted in 24 hours.
In do�s that lived five days or more it.amounted to
5 - 25%.

Rapid end marked hyperplastic chenges were
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noted in the pituitary gland; the basophilic elements
were the most affected.
Limarzi and Keeton(26) thought that the thyroid
gland may be involved in the production of this dis
ease, so they did a total thyroidectomy on one pa
tient sufferintz from polycythemia vera. They noted
that after several weeks the red cell count decreased
from 8,500,000 to 6,500,000, the total hemoglobin de
creased from 2,194 gm. to 1,224 gm.• , the plasma vol
ume increased from 1,927 to 2,436 cc., and the mean
corpuscular hemo�lobin increased from 26% to 31%.
The normal mean corpuscular,hemoglobin is 35% and
this indicates that the red blood cells are still
somewhat microcytic, and thus it takes a higher red
cell count to carry the normal amount of hemoglobin.
The white cell, differen�iel, and retieuloeyte counts

have remained unchanged and the patient was relieved
of all her symptoms; now her complaints were merely
those of myxedema.

It is evident that this patient

was given symptomatic relief from erythremia, but the
symptoms of myxede!Ilf:l Are not pleasBnt by any means
either, so it certainly should not be advised es a
form of treatment when better methods are available.
From all the available literature it appears that
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the endocrines probably do play a minor role in red

blood cell formation _indirectly, but are by no means
the answer to the problem of etiology.

The obscure etiology of erythremie has 1ed many

physiolo�ists to do considerable experimental work
on animals. Waltner,. Waltner, and'Orten and their

coworkers were able to ·produce polyeythemia in rats

by feedin� slI1811 amounts of cobalt; the presence of

.04 mg. in the entire body was sufficient to produce

an increase in the red eel l count. Orten postule.ted
that this erythrocytosis was due to the increased

rate of red cell and hemoglobin formation rather than

a mere passive accumulation by delayed destruction,

and he su��ested that cobalt probably produced its
effect by vasodilitetion end thus anoxemie.

These workers also showed that if ascorbic acid

was given with the cobalt no erythrocytosis resulted,

end if ascorbic acid was injected after the polycy

themia had developed it produced a temporary decrease
of both red cells end hemo�lobin.

They postulated

that ascorbic acid might be one of the re�ulators of
red blood cell for.rfletion. Palitz obtained an in

crease of 26% in the red count in dogs by artificial

fever end since this failed to occur in splenectomized
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do&1:s, he concluded that this was due to the contrac
tion of the spleen.

Davis{6) also did some experimental work on do�s;

after
producing
polycythemia in dogs with cobalt, he
.
.
.
found that the red cell count c·ould be· decreased by

feedin� liver or by injectin� liver extract.

When

the feedin� of liver was stopp_ed, ·the red cell count

be�an to rise again.

He also noticed that heated

liver extract failed to control the cobalt polycythe

mia.

He noted that ascorbic acid depressed cobalt

polyeythemia, 'hut it had no effect on polycythemia

due to low atmospheric pressure.

Cobalt seems to

have a �eneral biolo�ical property of stimulating

erythropoiesis when fed in physiological doses.

The

mode of action is not exactly known, but Kleinberg

considered that it acts directly on the erythropoi
etic center.

Barron's theory that cobalt produces polycythe

mia by inhibitin� the respiration of immature red

cells in the bone marrow is substantiated by some of

Devis' work.

He found that cobalt lowered the ascor

bic ecid content of the do�'s blood both in vivo and

in vitro.

Devis sup-Rests, however, that cobalt may

act indirectly by impairing a possible respiratory
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function or ascorbic acid.

Davis(5) found that polyeythemia could be pro

duced by the administration of ephedrine; he used

6 dotzs, ? rabbits, end one human in this experiment.

Re noted that the ora1 administration of 2,5 to. 5,0
m�./kilo. caused a si�nificant increase in the red
count of all subjects in 10 to 15 days.

The red·

count remained elevated during the administration of

the drug, but decreased as soon as the drug was stopp
ed.

Splenectomized dogs responded just as well as

non-splenectomized dogs; this rules out contr�ction
of the spleen es a possible cause for the elevated
red count.

The effect of another drug, amphetamine,

was the same when �iven in oral doses of 10 m�. daily.
Ephedrine was injected into 3 rabbits that already

h ad a cobalt �olycythemia and this caused a further
increase of½ to 1 million.

The expleination offered

by the author is logical and probably correct; he

su�gests that ephedrine and amphetamine reduce the

blood flow to the bone marrow by vasoconstriction,

and thus a local anoxia stimulates erythropoiesis.
Davis(?) noted further that the experimental

polycythemias could be depressed.by the feedin� of
choline hydrochloride; its effect was just as drastic
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as that produced by feeding raw Jiver or by injecting
liver extract.

As stated before, heated liver fail

ed to produce an effect; thus the active principle

wss proven to be thermolebile, and it probably is
choline.

Choline hydrochloride and liver will de

press both cobalt polyeythemia and polyeythemia due

to low atmospheric pressure as does sodium nitrite,
and all three are inhibited by atropine sulphate.

The actions of choline hydrochloride and liver must

be the same and it probably is e "muscarine" like
action.

They probably cause a vasodilitation in the

bone marrow and thus the local anoxie is removed
which was the stimulating factor.

Subcutaneous injections of .5 m�./kilo. daily of

mecholyl reduced the red counts in polycythemia pro
duced by cobalt, ephedrine, and amphetamine.

Mann

itol hexenitrate in daily doses of 30 mg. by stomach

tube had a similiar effect. Aminophylline in oral

doses of 100 mg. daily produced the same results ex
cept for the cobalt polycythemia; apparently amino
phylline has no effect on cobalt polycythemia.

The

explaination of this is very difficult and purely

speculative; the reason may be that aminophylline is
e weaker dilator, or that cobalt stimulates erythro-
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poiesis indirectly by interferin,:r. with a cellular
respiratory function of vitamin "C".

In all these

cases the white count remained unchan�ed and they

were without effect on the normal animel.

This fur

ther substantiates the view tha.t all these drup:s in
cludin� choline hydrochloride depress the experimen

tal polycythemias by vasodilitetion in the bone msrrow.

In spite of all this experimental work Kandel

and LeRoy found that ascorbic acid was ineffective

in patients suffering from polycythemia vera; Major
could obtain no results with liver extract.

Carpen

ter(3) used choline hydrochloride in the treatment

of erythremia for one month in adequate doses, but

saw no decrease in the red count.

He gave the drug

in doses of .2 P"Ill • three times daily.
Meyer (30) treated five erythremic patients with
liver and choline hydrochloride; three patients re-

ceived 300 /2'.Ill. 0 f raw liver daily for 10 to 14 days,

and showed no improvement.

The fo_urth patient re

ceived 300 P'lil• of raw liver for 32 days and then re
ceived 600 /2'.Ill. of choline hydrochloride for 9 days;
his red cell count decreased sli�htly but his hemo
�lobin and hematocrit values were unchan�ed.

The

fifth patient received 550 m�. of choline hydrochlo-
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ride for 12 days without effect.

These authors came

to the conclusion that raw liver and choline hydro
chloride are of no value in the treatment of polycy
themie vera.
Deeny(9) treated two cases of erythremia with
ascorbic acid, but he used sodium bicarbonate with
the ascorbic acid.

He gave 300 m�. of ascorbic acid

daily until saturation; then he increased the dose
to 400 mg. with 1 oz. of sodium•bicarbonate.

A mark

ed diuresis occurred following this procedure, but
it produced a marked fall in the red cell count.

He

noted that if ascorbic acid was given alone it was
without effect, but when given with sodium bicarbon
ate it was quite effective.

The red count rose when

the treatment was sto�ped, but it fell again when the
dru�s were readministered.

Of all the methods tried

only the last one gives any hope of further help, and
it is not very pleasant to the patient.

The rest of

the drugs are ineffective in the treatment of true
erythremia; it seems that erythremie has a different
stimulus than has been SUR,zested by all this exper
imentation.
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PATHOLOGY

The chief disorder of this disease is the mark

ed increase in the circulating red blood ce11s end
this is where the disease gets its name.

There is

also a marked increase in the total b1ood volume as

well as in the granu1.ar 1 eucocytes and p1.Bte1 ets.

Occasionally myelocytes are seen, but there is no

erythroblastic infi 1.tration of the lymphatic tissue.
Typically the blood is dark red, thick, and very

viscid.

The spleen is always enlarged and firm; the

enlar�ement is chiefly due to engorgement with blood,
but some of it is due to hyperplasia of the splenic
pulp.

The liver a1so is en�orged with blood; in fact

every organ in the body suffers from vascular engorge

ment, and thrombosis is extremely common.

The deep

red appearance of the marrow of the lon� bones is
evidence of increased hemopoietic activity.

Heden(l9) emphasized the fact that the total

blood volume is increased in erythremia and that this

increase is almost entirely due to the vast number of
red cells in the circulating blood.

The red cell

mass ner ki1o�rem of body weight is the most sensi
tive indicator of abnormality and is constantly in
creased in erythremia, but shows little change in
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symptomatic erythrocytosis.

The hi�hest authentic

red count recorded is 13,000,000 by Koester in 1.906.

It has been calcu.lated theoretically by Mann that
with red cells of normal size, a cubic mill.imeter

would be unable to contain them if the count exceed
ed 1.3,900,000.

The red cells may be of normal size,

but usually they ere somewhat smaller; most of them

VAry from 83 to 61 cubic microns, while the normal
size is 8'7 cubic microns.

If ell the red cells were

of the 61 cubic micron size, it would take 1.6,380,328

cells to fill one cubic millimeter.

It appears that

as the red count increases the size of the cells us

ually decreases; that is, the patient with a hi�h
count will usually have smaller cells.

Nucleated red

cells are not uncommon and always indicate increased
bone marrow activity; reticulocytes are quite common

and may account for 1 or 2% of the red cells.

Fre�

ility of· the red cells varies considerably, but it
is either norm.8 1 or sli�htly increased.

The platel.et count frequently is elevated; counts

of l,000,000 are ouite common, and counts as high as

3,000,000 end even 6,000,000 have been reported.

Since platelet counts ere not a routine procedure,

many cases of erythremia never have their platelet
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count taken.

This perhaps accounts for the fact that

not much literature deals with the platelet counts.
The leucoeyte count is practically always elevated;
it ll18Y, however, be unsffected or even decreased.
Parkes, Weber, and Bode in 1929 reported white counts
of 1,080 and 4,000, whil.e Cross in 1931 reported two
cases with counts of 6,?00 and 8,400.

Last year

(1942) Grunberg(1.8) recorded a case of erythremie in
a 44 year old ma1e who had a white count of 5,200 and
a normal diff'erentiel.

These may all be early cases

which later will develop the typical white blood pic
ture.
Nearly always, however, there is a leucooytosis,
and the polyrnorphonucleer neutrQphile is the predom
inant cell.

It frequently accounts for 75 to 85% of

the total white count; a shift to the left is invar
iably present end a few myelocytes are usually seen.
It is rather curious to note that neither Vaquez nor
Osler noted the moderate leueoeytosis.

Tflrck called

attention to it in 1902 end he sug�ested that the
whole bone marrow was hyperactive rather than merely
the erythropoietic tissue.

In Osler's patients the

white ce1l counts were over 10,000 in 50% of the
cases; Winthrope(46) reports that in 12 of his
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patients the white cell count was from 12,800 to 58,
000.

Polychromatopnilie, normoblests, myelocytes,

and myeloblasts have been reported and these are ell

ind3cat:ions of increased erythrop:enesis.

The myel

ocytes are increased relatively as well es absolutely

and the metamyelocytes are also frequently increased
as are the eosinopbi1s and basophils.

OccasionAlly the 1eucocytosis is so great as to

su��est a diagnosis of chronic myelogenous leukemia
if it were not for the markedly elevated red count.

Several cases have been reported which show si�s of
both diseases end the authors reportin� such cases

include Pendergrass, Pancoast, Hay; end Evans.

Zim

merman, Redenius, and Blumenthal reported several

cases which had the clinical end hematolo�ical pic

ture of erythre�ia end at autopsy the amount of

leucoblestic tissue greatly exceeded the amount of

erythroblastic tissue.

Of more si�ificence are

those cases which durinp: the course of a typical ery

thremia, a severe anemia develops while the leuco
cytosis remains hi�h or becomes even hip:her.

Further

evidence of the c1 ose association of .the two diseases
ere the cases of Herzheimer, Jun�, and Brieger in
which erythremia w�s fo11.owed by fatal acute
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myeloblastic leukemia.

In Jun,z's case the diai:znosis

was verified at autopsy.
The reverse sequence of events, that is, ery
thremia developin� in a case of typical leukemia, was
In his case he noted a rise in the

noted by Ghiron.

red count from 2,100,000 to 7,200,000 and at the same
time a marked erythema developed.

Neep:li reports a

case in which a high leucocyte count and myeloid hy
peractivity

WAS

followed two years later by a typical

polycythemia vera.

Of further interest are the two

cases reported by Gutzeit and Gu��enheimer who were
sufferin11. from typical erythremie while their immedi

ate predecessors suffered from leukemia.

Al 1. these

statistics indicate that there is an intimate rela
tion between erythremia end myelogenous leukemia,the
nature of which is still obscure; they probably both
are neoplastic diseases.
The symptoms of weakness, anorexia, and dyspnee
in this disease have led several physiolo�ist to in
vestip:ate the cardiac and respiratory functions of
the body.

Altschule(2) and his coworkers found them

to be normal in uncomplicated cases and they conclud
ed that the symptoms of erythremia were merely due
to the increased resistance to the flow of blood thru

31

the smell capillaries of the lun� which in turn was
due to the increased viscosity of the blood. · The

respiratory rate end minute vo\ume usually are in

creased ·in patients with erythremie who have an in-·
creased basal metabolic rate.

Blumenp:art, Harrop,

and Heeth also rel)9rt normal lunp: volpmes end nqrmal

resl)iretory rates in uncomplicated cases.

The car

diac function may� however, be affected especially
if erythremie is complicated by hypertension; the

condition is then called Geisbock's Syndrome.

Geisbock was the first one to describe e case

of erythremia with hypertension in 1905 and since

that time the condition has been called Geisbock's
Syndrome.

At present it is not considered a definite

entity because there is too much variation.

Some

patients have a splenomegaly with their polycythemia

and some do not; this shows that hypertension can

complicate both erthrocytosis and erythremia.

Some

authors, including Orlowski, think that these patients

have two separate disease entities.

Since the cause

o f hypertension is obscure in many cases without ery
thremia, it seems lo�ica1 to assume that it could
also occur in patients with erythremia.

Hypertension

in erythremia could be due to nephrosclerosis,
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chronic nephritis, or any vesculer complication of
erythremie in the kidneys, like thrombosis of so�e

o f the renal a·rterioles.

Some cases of erythremia

may even be complicated by an essential hypertension.
Stews rt, Wheeler, and Crane ( 41) observed the

cardiac output and related functions of the circula
tory system on six patients sufferinPs from polycy

themia vera.
They used the acetylene-method as was
•
recommended by Grollmann. · They noted that when the

Quantity of hemoglobin end red count were increased
above normal, the arteriovenous oxygen difference

was increased And the cardiac output and index were
decreased.

¥easurements of blood pressure, heart

rate, vital capacity, oxy�en consumption, and venous

pressure showed no consistent variation from the nor

mal.

They also observed one case when anemia develop

ed as the result of therapy and ap:ain when the nor

mal levels of red cells and hemo�lobin were restored.
They noted that as the red cell counts and hemoglobin

decreased under therapy, the erteriovenous oxy�en

difference decreased to normal and the cardiac out
put per beat increased to normal.

When anemia devel

oped the arteriovenous oxy�en difference decreased

below normal. end the cardiac output increased above
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normal.

These chan�es in circulation appear to be a com

pensatory mechanism in which the heart is spared the

burden of pumpin� an increased total volume of cir
culatinp: blood having an increased viscosity et a
normal velocity.

This can be easily explained by the

fact that the total oxy�en content of polycythemi.c

blood is markedly incre·ased. and the oxygen require

ment of the tissues can be satisfied by a cardiac out
put that is smaller than normal and.the maintenance

of a norm.al cardiac output under these circumstances

would impose needless work on the heart.

This view

is further substantiated by Grollmsn's observation
that when an individual moves from sea level to

dwell at a hiF-h altitude, the cardiac output is in

creased first, but as the :oolycythemia develops it

decreases a1lowin� increased oxygen carryin� power of

the blood to replace the orip:inelly increased cardiac

output.

· Y...ost authors report a normal saturation of the

arterial end venous bloods, but the capacity and con

t ent are �reatly inereased because of the increased
total blood volume.

The blood carbon dioxide con

tent end combining power are rather low; this
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evidently is due in pert to the fact thet the red

cells contain only 60% as much available base as

serum, and the serum is ler�ely replaced by red cells
in this disease.

Polycythemia vere blood contains

from 70 to 80% red cells while the normal blood only

contains 45% red cells.

It is clear that the lower

in� of the whole carbon dioxide content end combinin.o:

must occur; no detectable abnormality can be found in
the electrolytic pattern.

The basal metabolic rate

cated· cases it is normal.

Meinzer end Hersch studied

may be low, normal, or elevated; usually in uncompli
the blood of a·patient in great detail end concluded

that cyanosis is not due to anoxemia but to unsatura

tion.

They state that in anemia one sees enoxemia

without cyenosis and in polycythemia vera one sees
cyanosis without anoxemia.

Thomas end Stron� studied the dissociation curves

of normal and artificially produced polycythemic

bloods end they found ·no differen_ce in the oxygen
tension necessary to produce a given saturation.

When

these bloods were oxy�enated thru the perfused lung,

however, the normsl blood is completely saturated

while the concentrated blood is never saturated, but

increesin� the oxy�en tension increases the saturation
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of the concentrated blood.

These authors attribute

the difference between these two bloods to the diff

erent rate At which the concentrated blood passes

thru the lunP= with a delayed diffusion resultinp: from

capillary dilitetion.

Hirsch(20) took chest X-Rey films of patients

sufferinp: from erythremie end he.found that two types
of nodular lesions may occur in this disease.

One e

conglomeret tubercle which differs in no way from the

formation seen in e normal individual and the other

ty-pe which is e sharply defined nodular lesion which

is characterized by multiplicity, homo�eneity, end
transientness, end leavin� but little residue.

The

entire period of such a lesion may be less than three

weeks; he attributed it to a subpleurel thrombus or
a small interstitial hemorrha�e.

The patient usually

experiences no symptoms durin� the appearance of

t hese shadows.

It is interestin� to note here that

Rodes(39) reported one case of a cavernous heman�ioma

of the lunR with secondary polycythemie.

The roent

�eno�rams of the chest showed increased msrkin�s in

the hil.us of the right luni;i:.

The patient died six

months later from a pulmonary hemorrhage and autopsy
confirmed the diagnosis; no other cases have been
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reported in the literature thus far.

Hodes end Griffith(21) �ive a report on the ·diff

erential dia�nosis of polycythemie vera and po�ycythe

mie secondary to pulmonary arteriolosclerosis.

Since

the clinical picture is practically identical in both

diseases and since the treatment is radically diff
erent, accurate diaRnosis _is imperative.

Roent�eno

�rems of the chest are not absolutely diagnostic,·but

it certainly can afford some help in arriving at the
correct diagnosis.

In patients suffering from ery

thremia the chest plate·s reveal exap�erated truncal

shadows which are due to the marked.pulmonary en�orpe

ment; this has been proven amply at the operatinp:
table and at post-mortem examination.

The prominence

of the vascular shadows extends to the periphery of

the lun�s, and the cardiac silhouette is essentially

nonnal.

In patients with polycythemie secondary to

pulmonary arteriolosclerosis the mid- and peripheral
zones of th� lungs are normal or do not present the

vascular engor�ement while the pulmonary area end

silhouette of the ri�ht heart are increased in promi
nence.

In their small series of 11 cases, 8 were

diep:nosed correctly.
· There usually is a moderate or marked thickeri.inp:
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of the peripheral arteries, end vascular accidents
ere ouite common and frequently ere the _cause of
death.

Venous thrombosis is more common and probably

is due to the increased viscosity of the blood and
slu�gish circulation.

Thrombosis can occur in any

pert or or�an of the body and produce the most baff

ling clinical picture.

Thrombosis of cerebral, coro

nary, and mesenteric vessels as we·11 as those of the
lower extremities are reported by many authors.
Thrombosis of the upper extremity, however, is quite
rare.

Stover end Herrell (42) report a case of exten

sive thrombosis of the ri�ht subclavien and axillary
veins in a 66 year ol_d white male; two years pre
viously this patient suffered from thrombophlebitis
of the right le� which cleared up without leaving
any residual effects.

This patient wes treated by

elevation and heat locally and phlebotomy; in the

next 8 days 5,250 cc. of blood were removed end this
produced a very dramatic improvement in this extrem
ity.

This patient was controled by ecetylphenyl

hydrezine after this accident and he never suffered
any further vascular accidents.

These complications

and symptoms can usually be prevented if the patient's
red count is kept within normal limits by treatment.
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From this it is apparent that most of the patient's

complaints ere due to the slug�ish circulation which
in turn is due to the increased viscosity of the
blood.
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Up to this time there is no specific treatment

or cure for this disease; alt the methods of treat

ment are merely symptomatic and attack the disease

from two different standpoints, that is, destroyin,o:

the excess red cells by various drugs, or prevent

the formation of excess red cells by various methods.
Benzel was one of the first drugs used to de

stroy the excess red cells, but it proved to be too
toxic.

It did reduce the patient's red count, but

the patient suffered more from the toxic manifesta
tions of the drup, than from the disease itself, so

the use of it was rapidly abandoned.

Phenylhydrazine

was one of the next drugs that proved to be very ef

fective and was much less toxic than benzol. However,

it still is toxic and the patient has to be under
constant supervision while taking the drug.

This

drup is now replaced by one of its. own derivatives,

ecetyl:phenylhydrazine, which is still less toxic and
just as effective.

The usual dose is .1 gm. in a

oapsul daf.1y for a week if the patient is under
strict supervision in a hospital.
not in a hospital, .1

,91n.

If the patient is

is �iven every other day
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and a red celJ count is taken every week; then as the
count decreases the dose�e is decreased until the

m aintainence dose is found which varies from .1 pm.
per week to .l gm. every other day.

In cases not

eom�1iceted by renal or liver damage, or essential

hypertension, the druF can be given over long periods
of time without any deleterious effects.

Falconer(l4) treated 11 patients, who had clin

ical and laboratory diagnosis of erythremia, with
lead.

Leed acetate was used orally in doses of .3 gm.

in C8psuls, end parenterally colloidal lead phosphate
was used.

The parenteral dose was 10 cc. intrave

nously; each cc. contained from 3.7 to 3.8 mg. of

metallic lead.

The total dose during the year period

varied from 3 to 20 �., and in all cases the amount

was always kept below the toxic level.

In this seri

es the patients came from all walks of 1ife and were
taken at random.

The severity of the disease varied

considerably in this series; the more severe cases

required more treatment and remissions were shorter.

In one mild case the remission lested 6 yeers, and

previously this patient had been treated with phenyl
hydrazine end the 1.onpest remission was 8 months.

Up

to the time that this report was made, no permanent
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or serious toxic effects have occurred in any of the
cases treated.

Six of the-11 patients treated with

lead were previously treated with phenylhydrazine,

and they re�arded this drug as more toxic and disa
blin� than lead and were unwilling to submit to fur
ther treatment with it.

From this series it appears

that lead is efficient in controling the symptoms

end reducin� the red eel l count·, but the dangers of
this dru� are reel end the dru� should not be used
un1 ess the patients are carefully supervised.•

Potassium. arsenite or Fowler's Solution as it

is frequently cal1ed is also effective.in polycythe

mie vera end can be used over long periods of time
without producing symptoms.

The mode of its action

is not definitely known, but most authorities think

that it is a regulator of red cell formation and not
a de�ressant to the bone marrow.

Reznikoff used it

with X-Ray and reported good results.

However, for

some reason or other it has been largely replaced by
acetylphenylhydrazine; probably because it is just

as effective and not nearly as toxic.

It is rather curious to note in this connection

that the sulfadrugs also will depress red cell for
mation in polyeythemie vera.

Greenweld(l?) reported
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one case of erythremia who was �iven 33 gm. of sul

fenilamide over a �eriod of 7 days for acute prosta

titis and the patient developed toxic manifestations

of the bone marrow; He developed anemia, leucopenia,
and neutropenia; the drug was stopped immediately

and three transfusions were given ove·r a period of
three weeks and.the patient made an uneventful re
covery.

Blood studies 6 months later showed a re

tum to the previous hif!h levels.

This incident, it appears to me, may serve as a

clue �o some investigators, to try to find or make a
sulfedru� which is quite toxic and exerts its effect

solely on .the bone marrow; such a preparation could ·

then.be Fiven in minute
doses to ' control erythremia.
.

This idea may not seem probable at this time, but it

certainly is possible with the rapid advance now
bein� made with these drugs.

Phlebotomy or venisection is another method of

treatment which can be used alone or in combination
with the other methods of treatment; it �ives imme

diate relief and appears to have no deleterious ef
fects upon the bone marrow.

Stephens studied this

method of treatment very carefully and found that

it neither depressed nor stimulated the bone marrow.
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Reznikoff treated a patient by phlebotomy once a
month for 5 years without any _bed e_ffeets; the pa

tient's count remained norm.el and there never were

a ny untoward symptoms.

Holbrook(22) did venisections on 10 patients

with erythremia and he concluded from his series· that

it is a safe end reas�nably effective forni.. of therapy.
.

'

The withdrawal of approximately 400 cc. of blood can

be expected to give prompt relief of such symptoms as
headache, unpleasant heat sensations, palpitation,

dyspnea, 8nd nervousness, and to reduce -the red count,
hemogl_obin, and viscosity tempo·rarily.

The withdraw

als of ?00 to ?50 cc. were found to be Jess -effective
than the usual amount of 400 cc.

It must be remem

bered that if a norm.cl red cell count and hemoglobin

are produced rapidly in an erythremic_patient, he or

she may suffer from a relative anemia; it takes some

time for the respiratory and circulatory systems to
readjust themselves.

The blood viscosity tests have

proven to furnish a reliable means in fo1..lowinp; the
resnonse of a patient.

No reticulocyte responses

were encountered in 15 tests made after venisections
yielding 350 to 750 cc.

Studies on the blood volume

before end after venisection indicate that it is
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rapidly replaced by body fluids.
Radiation is another form of treatment and be

lonir.s to that �roup which prevents blood formation-.

It can be employed in two different ways, that is,
"Spot Radiat:ion" and "Spray Radiation".

In "Spot

Radiation" various regions of the-body are treated;
the unita�e varies but usua1·1y 50 roentgens are giv

en at each treatment end the location is varied with
each treatment.

There is no good evidence available

at this time that X:-Rey decreases the -size of the

�pleen when enlargement is simply due to congestion

and hyperplasia, but it proves quite effective when
enlarp:ement is due to myeloid metaplasia.

In "Spray

Radiation" the whole body is exposed to X-Ray; 50

roentpens are usual�y gi-ren three times per week for
3 to 6 treatments.

'Ihis method is quite effective

and well tolerated, but the blood has to be checked
frequently to prevent the development of anemia.

This method is not used very much because it is much

simpJer to administer one of the hemolytic drugs.

Erf and Lawrence(13) developed an entirely new
method of treatment, and that is by the use of radio

active phosphorus; the full value of it has not been
determined because its discovery is too recent.
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They used the dru� on 10 petien�s, 4 of which were

normal and 6 of them hed clinical end laboratory di

a�osis of polycythemia vera.

No chan�es were noted

durin� or followin� the administration of 1 .5 mi1 li
curies of radioactive phosphorus; one millicurie is

equal to 1000 microcuries or 3,700,000 beta particles·

per second.

Three patients received the dru� intra

venously and the fourth received it orally.

Blood

studies revealed that the red cells contained most

of the radioactive phosphorus in the first 36 hours,

after which time the white cells had the highest con

tent.

As could be seen from their �raph, the reten�

tion of radioactive phosphorus in the red cells and
plasma of both norm�d individuals and patients with

polycythemia vera were nearly identical re�ard1ess of

the route of administration.

However, the retention

of radioactive phosphorus in the red cells was higher

in both proups followin� the intravenous route than
by the oral route.

The erythremic patients were

�iven ell the way from 12.34 to 48.82 millicuries of

the drug denendin,:i: upon the severity of the disease
and previous therapy. All ceses showed clinical

symptomatic And sub;lec.tive improvement for three
months to one year, depending upon the amount of the
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drug given and the severity and duration of the disease.
The normal individuals excreted from 25 to 5�
of the dose of the drug in the urine and feces in 6
days, re�ardless of the route of administration.

The

patients with erythremia excreted less than 25% of
the dose in 6 days; the reason for this has not been
explained, but-it could be due to the fact that the
hyperactive bone marrow hes a p:reater affinity for
the radioactive phosphorus.
The radioactive phosphorus which was used in
this experiment emits beta particles which can pro
duce ionization and ·thus its effect is fundamentally
and basically identical with that of X�Ray.

Radio

active phosphorus, however, has an advantage in that
it concentrates in the bone marrow, and since its
half life is 14.3, it can bombard that tissue for
many days withou� affecting other tissues unnecessa
rily.

In three patients a fairly high dose of the

dru� had to be give� intravenously to produce an ef
fect, probably because the concentration did not get
hi�h eno�gh by ora1 administration.

Results were

obtained about 100 days efter an effective dose was
given and this is about the life span of the red
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cells.

In none of these cases were any toxic symp

toms noted by the patient, such as nausea, vomitin�,
headache, or any other subjective symptom.

On the

contrary, it produced a marked improvement in the

clinical picture and,consequently, this form of ther
apy can be advocated at this time.

In all these

cases the clinical im�rovement was just as great as
the hematological improvement.

Erf end Tuttle(l2) treated another series· of

four patients with this drug.

One patient had myel

oid leukemia, another had lymph9id leu�emia, and the
two remaining ones had erythremie
. . __Both erythremic
patients received 6000 micro9uries of the drup:, and

detailed blood studies were carried ·out on all cases.
They found that the greatest amounts of radioactive

phosphorus were retained in the "acid soluble" frac
tion of the red cells, white cells, and plasma of
all patients.

The
neak
of concentration
was reached
.
.
.

in 12 to 24 hours after . administration a�d then �rad
ua l ly decreesed -as did_ the "phospholipid" and "nu

cleoprotein" fractions of the red cells.

One patient

was given eQual amounts of the dru� orally and intra
venou�ly end it was found that much �rester quanti
ties were retained in ell fractions when Riven
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intravenously.

The level of radioactive phosphorus

in the "nucleoprotein" fraction reached a peak before
48 hours and decreased while the "phospholipid" frac

tion increased for 21 days after administration.
the white cells the level of the drup: retention in

In

both "phospholipid" end "nucleoprotein" fractions in
creased constantly for 96 hours, but not for 21 days.

In the plesmA the "phospholipid" retention increased

and the "nucleoprotein" fraction decreased durinp: the

same period.

This series was reported merely to show

the distribution of radioactive phosphorus in the

elements of the blood.

SUMMARY

The etiology of polycythemia vera still is ob
scure, but the wei�ht of evidence is in favor of the
neoplastic theory.

The disease lacks malignant fea

tures because it concerns chiefly an inert cell, the

erythrocyte, which is merely an oxy�en carrier of

the blood; it has no phagocytic powers like the white
cells which show abnormal cell types and invasive

features early.

There is no cure for this disease,

but there are several methods of treatment which ad
equately control the disease and p;ive. spptomatic
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relief.

Phlebotomy, radiation, and the administration

of lead and acetylphenylhydrazine have proven to be

very effective; acetylphe�ylhydrazine probably is the

most effective and least toxic of the hemolytic drugs.
Phlebotomy �ives immediate relief while it usually

takes from 7 to 10 days for the hemolytic dru�s to

nroduce an effect.

Apparently radioactive phosphorus

will prove to be another effective dru�, but its dis
covery is too recent to determine its value.

The

prognosis is poor because the disease is progressive
and ultimately proves fatal.
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